“…Anilinoquinazolines in particular are potent inhibitors of growth factor receptor tyrosine kinase (GFRTK) and have found clinical applications in epidermal and vascular endothelial GFR targets (Grunwald and Hidalgo, 2003). Quinazolinone heterocycles possess diverse pharmacological activities including antimycobacterial (Karel et al, 2001) antifungal (Sawhney et al, 1980) antimalarial (Martin et al, 1964), antihypertensive (Dienei et al,1973), antihistaminic (Alagarsamy et al, 2005(Alagarsamy et al, , 2006, local anesthetic (Chandrasekhar et al,1986) anti-Parkinson (Naithani et al, 1989), antiviral (Alagarsamy et al,2004), and thymidylate synthase inhibitory activities (Hennequin et al,1996). The simple and condensed quinazolinones are also known to exhibit analgesic (Alagarsamy and Murugesan, 2007), anti-inflammatory (Ravishankar et al, 1984) and anticonvulsant activities (Hori et al,1990).…”